Pain and Suicide: A Silent Epidemic
Death by suicide has become a global epidemic. Every 40 seconds someone in the world dies of suicide. An estimated 804,000 suicide deaths occurred worldwide in 2012. Individuals with chronic pain commonly have significant concomitant psychiatric and medical disorders placing them at higher risk for suicide with the prevalence of suicidal ideation in this patient population ranging from 19% to greater than 50%. One recent systematic review revealed that the risk of successful suicide was doubled in patients with chronic pain as compared to non-pain controls.
This presentation will review the current conceptual model of depression and suicidal ideation in patients with chronic pain, possible mediators and outline risk assessment strategies and discuss interventions to mitigate risk of suicide in this vulnerable population.
Pain and Suicide: A Silent Epidemic
Wednesday, June 7, 2017
1) Describe the interpersonal theory of suicide and its application in the pain population
2) Examine the psychological processes exacerbating suicidality in chronic pain
3) Demonstrate effective interventions to reduce risk of suicidal behavior in pain patients
Continuing Medical Education
This event is eligible for AMA PRA Category 2 Credit(s)™ where physicians may self claim one (l) AMA PRA Category 2 Credit for each 60-minute hour engaged in the learning activity. Individual physicians may claim AMA PRA Category 2 Credits for learning experiences that have improved the care they provide their patients and may be earned for activities physicians have undertaken on their own that should be beneficial to their practice.
Drexel University School of Medicine
245 North 15th Street, Philadelphia
Parking is available at the Gateway parking lot across from the auditorium and behind Magee and costs $5.00 after 5:00pm
Martin D. Cheatle, PhD
Associate Professor, Perelman School of Medicine, University of Pennsylvania
Dr. Cheatle earned his PhD in psychology at Princeton University. He completed his clinical internship at the University of Pennsylvania, School of Medicine and founded the Orthopaedic Pain Center at PENN. Currently he is Director of Behavioral Medicine at the PENN Pain Medicine Center; Director, Pain and Chemical Dependency Research at the Center for Studies of Addiction, University of Pennsylvania and Director Behavioral Medicine Center at the Reading Health System. He is an Associate Professor of Psychology in Psychiatry, Perelman School of Medicine, University of Pennsylvania. Dr. Cheatle specializes in the evaluation and treatment of chronic pain disorders from a biopsychosocial perspective and has been involved in extensive research including a NIH funded 5-year longitudinal study of the development of addiction in patients initiating prescription opioid therapy for chronic pain and as PI of a recently funded NIH study of phenotypic and genotypic markers of prescription opioid abuse. He is co-editor of the Pain Medicine journal Opioids, Substance Abuse and addictions Section. His main focus of research is pain management and addiction in vulnerable populations (HIV/AIDS, psychiatric patients) and pain and suicidal ideation and behavior.
1. Cheatle, M.D., Depression, chronic pain, and suicide by overdose: On the edge. Pain Medicine 12 Suppl 2: S43-S48, 2011.
2. Cheatle, M.D., Klocek, J, McLellan, A.T. Managing pain in high-risk patients within a patient-centered medical home. TBM. 2012; 2:47-56. PMCID:PMC3717821
3. Cheatle, M.D., Savage, S.R. Informed consent in opioid therapy: A potential obligation and opportunity. Journal of Pain and Symptom Management 44: 105-116, 2012.
4. Cheatle, M.D. Suicidal ideation in patients with chronic pain: The risk/benefit of pharmacotherapy. Pain, 155 (12): 2446-2447, 2014.
5. Cheatle, M.D., Wasser, T., Foster, C., Olugbodi, A., Bryan, J., Prevalence of suicidal ideation in patients with chronic noncancer pain referred to a behaviorally based pain program. Pain Physician, 17: E359-E367, 2014.
6. Cheatle, M.D., Comer, D., Wunsch, M., Skoufalos, A., Reddy, Y. Treating pain in addicted patients: Recommendations from an expert panel. Population Health Management 2014; 17 (2):79-89. PMCID:PMC399699
7. Cheatle, M.D., Baker, C. Improving opioid practices and reducing patient risk in the primary care setting. Journal of Pain Research, 7: 301-311, 2014. PMCID: PMC4062552
8. Dhingra, L., Perlman, D.C., Masson, C., Chen, J., McKnight, C., Jordan, A.E., Wasser, T., Portenoy, R.K., Cheatle, M.D. Longitudinal Analysis of Pain and Illicit Drug Use Behaviors in Outpatients on Methadone Maintenance. Drug and Alcohol Dependence, 149: 285-289, 2015.
9. Wachholtz, A., Foster, S., Cheatle, M.D. Psychophysiology of pain and opioid use: Implications for managing pain in patients with an opioid use disorder. Drug and Alcohol Dependence, 146:1-6, 2015
10. Cheatle, M.D. Biopsychosocial approach to assessing and managing patients with chronic pain. Medical Clinics of North America 100 (1): 43-53, 2016.